These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 30960288)
1. Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery. Lu B; Lv X; Le Y Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960288 [TBL] [Abstract][Full Text] [Related]
2. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
4. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles. Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983 [TBL] [Abstract][Full Text] [Related]
6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
7. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390 [No Abstract] [Full Text] [Related]
8. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine. Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070 [TBL] [Abstract][Full Text] [Related]
9. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity. Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731 [TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
14. Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine. Zheng H; Pan L; Lv J; Zhang Z; Wang Y; Hu W; Liu X; Zhou P; Wang Y; Zhang Y Microb Pathog; 2020 Feb; 142():104061. PubMed ID: 32061916 [TBL] [Abstract][Full Text] [Related]
15. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
16. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide. Shi Y; Xue J; Jia L; Du Q; Niu J; Zhang D Colloids Surf B Biointerfaces; 2018 Jan; 161():67-72. PubMed ID: 29040836 [TBL] [Abstract][Full Text] [Related]
17. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan. Li Z; Xiong F; He J; Dai X; Wang G Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030 [TBL] [Abstract][Full Text] [Related]
18. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery. Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
20. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma. Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]